New in @JAMAPsych: GLP-1 prescribing increased among adults with and without serious mental illness from 2018–2024. However, among adults with diabetes, those with schizophrenia had lower GLP-1 use—highlighting an opportunity to improve care. jamanetwork.com/journals/jam...
jamanetwork.com
GLP-1 Prescriptions Among People With and Without Serious Mental Illness
This cross-sectional study examines glucagon-like peptide-1 (GLP-1) prescriptions among adults with vs without severe mental illness from 2018 to 2024 using national insurance claims.